Skip to main content
. 2015 Jul 1;6(19):16926–16938. doi: 10.18632/oncotarget.4700

Figure 1. Characterization of lung CSCs and their resistance to conventional chemotherapeutic drugs.

Figure 1

A. Expression of CD133 detected by flow cytometry in the indicated lung CSC line (LC1). B. Lung CSCs (Stem) and the corresponding differentiated progeny (Diff) treated for 72 h with chemotherapeutic drugs. Cell viability was measured by Cell-Titer-Glo Assay. The experiments were performed with 2.5 μg/ml cisplatin, 50 μM gemcitabine or 30 ng/ml paclitaxel. Bars shown are the mean ± S.D. of three independent experiments. *P-value <0.05 and **P-value <0.01.